Andre A D'hemecourt, MD | |
2 Pillsbury St Ste 100, Concord, NH 03301-3502 | |
(603) 228-1104 | |
(603) 228-7061 |
Full Name | Andre A D'hemecourt |
---|---|
Gender | Male |
Speciality | Ophthalmology - Glaucoma Specialist |
Location | 2 Pillsbury St Ste 100, Concord, New Hampshire |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1144214461 | NPI | - | NPPES |
0105185Y0NH01 | Other | NH | ANTHEM NH |
00000648 | Medicaid | NH | |
180026676 | Other | NH | RAILROAD MEDICARE |
5920277001 | Other | NH | CIGNA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | 6873 (New Hampshire) | Secondary |
207WX0009X | Ophthalmology - Glaucoma Specialist | 6873 (New Hampshire) | Primary |
Mailing Address | Practice Location Address |
---|---|
Andre A D'hemecourt, MD 2 Pillsbury St Ste 100, Concord, NH 03301-3502 Ph: (603) 228-1104 | Andre A D'hemecourt, MD 2 Pillsbury St Ste 100, Concord, NH 03301-3502 Ph: (603) 228-1104 |
News Archive
Inhalable nanocatchers that contain hACE2 have been recently developed by a group of researchers, providing a plethora of potential benefits in comparison to existing treatments against COVID-19.
A recent study published in the preprint server medRxiv in September 2020 shows that the effect of climatic factors such as temperature and humidity is mediated mostly through human mobility. Thus, human behavioral changes are still the mainstay of containment rather than hoping for weather conditions to keep the virus at bay.
Reports from the United States that authorities there have approved a handgun designed for those crippled by conditions such as arthritis and muscular dystrophy have given rise to confusion and debate.
Canyon PharmaceuticalsTM (www.canyonpharma.com) today announced the availability of Iprivask (desirudin for injection), the first direct thrombin inhibitor (DTI) approved in the United States by the Food and Drug Administration for the prevention of deep vein thrombosis (DVT), which may lead to pulmonary embolism in patients undergoing elective hip replacement surgery.
› Verified 9 days ago
Maynard B Wheeler, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 248 Pleasant Street, Suite 1600, Concord, NH 03301 Phone: 603-224-2020 Fax: 603-228-0248 | |
Maxwell Arrington Snead Iii, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2 Pillsbury St Ste 100, Concord, NH 03301 Phone: 603-228-1104 | |
Dr. Tighe Curtis Richardson, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2 Pillsbury St Ste 100, Concord, NH 03301 Phone: 603-224-2020 Fax: 603-228-7061 | |
Christie L Morse, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 248 Pleasant St, Suite 1600, Concord, NH 03301 Phone: 603-224-2020 Fax: 603-228-0248 | |
David Alan Weinberg, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 248 Pleasant St Ste 1600, Concord Eye Care, Concord, NH 03301 Phone: 603-224-2020 Fax: 603-228-0248 | |
Bradford S Hall, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 248 Pleasant St, Ste 1600, Concord, NH 03301 Phone: 603-224-2020 Fax: 603-228-0248 |